Pharmaceutical

Microbiome company Enterome plans $108m raise to fund Phase II cancer trials

The latest fundraise will close in 2024, with plans for one Phase II trial to start by mid-2024.

Aug 26, 2023 - 20:00
Microbiome company Enterome plans $108m raise to fund Phase II cancer trials
The latest fundraise will close in 2024, with plans for one Phase II trial to start by mid-2024.
Read the original article

Tags:

Previous Article

FDA approves the first Tysabri biosimilar for MS and Crohn’s disease

Next Article

AstraZeneca scores its second paediatric approval for Soliris in Japan

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Uppsala and KTH Royal develop antibody for potential cancer treatment

Uppsala and KTH Royal develop antibody for potential ca...

Nov 13, 2024

Bayer reports drop in Q1 sales amidst patent litigation challenges

Bayer reports drop in Q1 sales amidst patent litigation...

May 15, 2024

Casgevy: Launch sequence and price analysis of the first marketed CRISPR therapy

Casgevy: Launch sequence and price analysis of the firs...

Aug 3, 2024